Search Results - Aziz Nazha

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    The Evolving Landscape of Myelodysplastic Syndrome Prognostication by Jacob Shreve, Aziz Nazha

    Published in Clinical Hematology International (2020-04-01)
    Get full text
    Article


  2. 2

    The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia by Aziz Nazha, Carlos G. Romo, Hagop Kantarjian, Jorge Cortes

    Published in Haematologica (2013-10-01)
    Get full text
    Article


  3. 3

    Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence by C. Beau Hilton, Alex Milinovich, Christina Felix, Nirav Vakharia, Timothy Crone, Chris Donovan, Andrew Proctor, Aziz Nazha

    Published in npj Digital Medicine (2020-04-01)
    Get full text
    Article


  4. 4

    Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia by Aziz Nazha, Jorge Cortes, Stefan Faderl, Sherry Pierce, Naval Daver, Tapan Kadia, Gautam Borthakur, Raja Luthra, Hagop Kantarjian, Farhad Ravandi

    Published in Haematologica (2012-08-01)
    Get full text
    Article


  5. 5

    Personalized Prediction of Hospital Mortality in COVID-19–Positive Patients by Daniel Rozenbaum, MD, Jacob Shreve, MD, MS, Nathan Radakovich, MD, Abhijit Duggal, MD, MPH, MSc, Lara Jehi, MD, MHCDS, Aziz Nazha, MD

    Get full text
    Article


  6. 6

    Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes by Aziz Nazha, David Seastone, Tom Radivoyevitch, Bartlomiej Przychodzen, Hetty E. Carraway, Bhumika J. Patel, Jennifer Carew, Hideki Makishima, Mikkael A. Sekeres, Jaroslaw P. Maciejewski

    Published in Haematologica (2015-11-01)
    Get full text
    Article


  7. 7

    Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months by Aziz Nazha, Hagop Kantarjian, Preetesh Jain, Carlos Romo, Elias Jabbour, Alfonso Quintas-Cardama, Raja Luthra, Lynne Abruzzo, Gautam Borthakur, Farhad Ravandi, Sherry Pierce, Susan O’Brien, Jorge Cortes

    Published in Haematologica (2013-11-01)
    Get full text
    Article


  8. 8

    Molecular features of early onset adult myelodysplastic syndrome by Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Tomas Radivoyevitch, Bhumika Patel, Swapna Thota, Michael J. Clemente, Yasunobu Nagata, Thomas LaFramboise, Hetty E. Carraway, Aziz Nazha, Mikkael A. Sekeres, Hideki Makishima, Jaroslaw P. Maciejewski

    Published in Haematologica (2017-06-01)
    Get full text
    Article


  9. 9

    Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation by Jing Dong, Christopher Staffi Buradagunta, Tao Zhang, Stephen Spellman, Yung-Tsi Bolon, Amy E. DeZern, Shahinaz M. Gadalla, H. Joachim Deeg, Aziz Nazha, Corey Cutler, Chao Cheng, Raul Urrutia, Paul Auer, Wael Saber

    Published in Journal of Hematology & Oncology (2023-03-01)
    Get full text
    Article


  10. 10

    Distinct clinical and biological implications of CUX1 in myeloid neoplasms by Mai Aly, Zubaidah M. Ramdzan, Yasunobu Nagata, Suresh K. Balasubramanian, Naoko Hosono, Hideki Makishima, Valeria Visconte, Teodora Kuzmanovic, Vera Adema, Aziz Nazha, Bartlomiej P. Przychodzen, Cassandra M. Kerr, Mikkael A. Sekeres, Mohamed E. Abazeed, Alain Nepveu, Jaroslaw P. Maciejewski

    Published in Blood Advances (2019-07-01)
    Get full text
    Article


  11. 11

    The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure by Aziz Nazha, Rami S. Komrokji, Guillermo Garcia-Manero, John Barnard, Gail J. Roboz, David P. Steensma, Amy E. DeZern, Katrina Zell, Cassie Zimmerman, Najla Al Ali, Elias Jabbour, Molly D. Greenberg, Hagop M. Kantarjian, Jaroslaw P. Maciejewski, Alan F. List, Mikkael A. Sekeres

    Published in Haematologica (2016-06-01)
    Get full text
    Article


  12. 12

    Genomics of therapy-related myeloid neoplasms by Teodora Kuzmanovic, Bhumika J. Patel, Srinivasa R. Sanikommu, Yasunobu Nagata, Hassan Awada, Cassandra M. Kerr, Bartlomiej P. Przychodzen, Babal K. Jha, Devendra Hiwase, Deepak Singhal, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Tomas Radivoyevitch

    Published in Haematologica (2020-03-01)
    Get full text
    Article


  13. 13

    Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes by Caner Saygin, Ashwin Kishtagari, Ryan D. Cassaday, Natalie Reizine, Ilana Yurkiewicz, Michaela Liedtke, Wendy Stock, Richard A. Larson, Ross L. Levine, Martin S. Tallman, Jae H. Park, Cassandra Kerr, Bartlomiej Przychodzen, Mikkael A. Sekeres, Matt E. Kalaycio, Hetty E. Carraway, Betty K. Hamilton, Ronald Sobecks, Aaron Gerds, Sudipto Mukherjee, Aziz Nazha, Jaroslaw P. Maciejewski, Anjali S. Advani

    Published in Blood Advances (2019-12-01)
    Get full text
    Article


  14. 14

    The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort by Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A. Sekeres, Andrew M. Brunner, Gail J. Roboz, David P. Steensma, Vijaya R. Bhatt, Uwe Platzbecker, Thomas Cluzeau, Pedro H. Prata, Raphaël Itzykson, Pierre Fenaux, Amir T. Fathi, Alexandra Smith, Ulrich Germing, Ellen K. Ritchie, Vivek Verma, Aziz Nazha, Jaroslaw P. Maciejewski, Nikolai A. Podoltsev, Thomas Prebet, Valeria Santini, Steven D. Gore, Rami S. Komrokji, Amer M. Zeidan

    Published in Blood Advances (2018-07-01)
    Get full text
    Article


Search Tools: